Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph plus) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993).

Bibliographic Details
Main Authors: Goldstone, A, Prentice, H, Durrant, J, Franklin, I, Harrison, G, Richards, S, Lazarus, H, Wiernik, P, Tallman, MS, Rowe, J
Format: Journal article
Published: 2001